Mark Findlay

Biography

 Mark Findlay is the Vice President, Cardiovascular & Metabolic at AstraZeneca Canada, a leading Canadian biopharmaceutical company.  Mark brings more than 20 years of marketing, sales and patient access experience within the pharmaceutical industry to the role, including strong expertise in both cardiovascular and diabetes. 

Research Interest

 Since joining AstraZeneca nearly 12 years ago, Mark has made important contributions to the company across many senior roles and functions. In his most recent role as Vice President, Patient Access & Established Brands – a role he also held prior to joining AstraZeneca U.S. – Mark led his team in strengthening access to our medicines for Canadian patients. Prior to this role, he was in the U.S. in the role of Senior Director, Early Launch Marketing – Lesinurad, with AstraZeneca Specialty Care and a member of the U.S. Specialty Care Leadership Team. Mark lives in Burlington with his wife Jackie and two children.